Global Thoracic Outlet Syndrome Market 2018-2023 Ongoing Trend | Growing at Remarkable CAGR of 7.0% with Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc

An expert on premium research reports, Market Research Future has added a report titled "Global Thoracic Outlet Syndrome Market 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top Market Players across the Globe.

Market Scenario

Thoracic outlet syndrome is a group of heterogeneous and disabling upper-extremity disorders that occur due to extrinsic compression of neurovascular structures between the clavicle and the first rib. There are three distinct types of thoracic outlet syndrome viz. neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome. Neurogenic thoracic outlet syndrome is most common, i.e., it constitutes around 85%-90% of thoracic outlet syndrome cases. Venous thoracic outlet syndrome constitutes around 10%-15% of thoracic outlet syndrome cases, whereas arterial thoracic outlet syndrome is found in 2%-5% of thoracic outlet syndrome cases.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5548

Rising cases of trauma and car accidents are boosting the growth of the thoracic outlet syndrome market. Chest injury is one of the causes of thoracic outlet syndrome, and this comes about as a result of traffic accidents in which the collarbone is broken, and the upper ribs are injured. As per the World Health Organization (WHO) report, nearly 20-50 million people incur non-fatal injuries as a result of road traffic accidents.

It is estimated that thoracic outlet syndrome market is expected to grow at a CAGR 7.0% during the forecast period of 2017-2023.

Other factors such as increasing cases of anatomical defects, high unmet needs of current treatment, and surge in the research and development expenditure, improvement in reimbursement policies are also expected to drive the growth of the market. According to a study published in the Current Issues in Pharmacy and Medical Sciences - De Gruyter journal in 2015, it is found that bone abnormality may be a potential cause of thoracic outlet syndrome. The most common bone abnormalities include irregularities of the clavicle (20%), the cervical rib (70% of cases), and in the different structures of the first rib (10%).

Despite these drivers, there are some issues associated with thoracic outlet syndrome market. Lack of infrastructure in the middle and low-income countries and side effects associated with the drugs may hamper the growth of the market.

Segmentation

The thoracic outlet syndrome market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.

On the basis of treatment, the market is segmented into surgery, medications, physical therapy, and others. The medications segment is further classified into muscle relaxant, thrombolytic medications, anticoagulant medications, and others.

On the basis of end-user, the market is segmented into hospital & Clinics, diagnostic centers, academic and research institutes, drug pharmacies, and others.

On the basis of diagnosis, the market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), and magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.

Regional Analysis

The Americas dominate the thoracic outlet syndrome market owing to the rising awareness among people, and increasing healthcare expenditure. As per the facts suggested by the Centers for Disease Control and Prevention (CDC), out of the total annual healthcare expenditure, 86% is for people with chronic health conditions in the United States.

Europe holds the second position in the thoracic outlet syndrome market. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe.

Asia Pacific is the fastest growing in thoracic outlet syndrome market, owing to a huge patient pool, developing healthcare technology, and rising healthcare expenditure in some countries within this region. According to the Australian Institute of Health and Welfare, in the years 2015 to 2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014–15.

The Middle East & Africa has the lowest market for thoracic outlet syndrome due to lack of technical knowledge and poor medical facilities.

Key Players

Some of key the players in the market are Abbott Laboratories, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endo Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt plc., Orient Pharma Co., Ltd., Par Sterile Products, LLC., Sanofi, SteriMax Inc., Upsher Smith Laboratories, Inc., Vertical Pharmaceuticals LLC, and others.

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/thoracic-outlet-syndrome-market-5548

Detailed Table of Contents:

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.